Guillain-Barre and Miller Fisher syndromes--new diagnostic classification.

Journal article

Guillain-Barré syndrome (GBS) and its variant, Miller Fisher syndrome (MFS), exist as several clinical subtypes with different neurological features and presentations. Although the typical clinical features of GBS and MFS are well recognized, current classification systems do not comprehensively describe the full spectrum of either syndrome. In this Perspectives article, GBS and MFS are classified on the basis of current understanding of the common pathophysiological profiles of each disease phenotype. GBS is subclassified into classic and localized forms (for example, pharyngeal-cervical-brachial weakness and bifacial weakness with paraesthesias), and MFS is divided into incomplete (for example, acute ophthalmoparesis, acute ataxic neuropathy) and CNS subtypes (Bickerstaff brainstem encephalitis). Diagnostic criteria based on clinical characteristics are suggested for each condition. We believe this approach to be more inclusive than existing systems, and argue that it could facilitate early clinical diagnosis and initiation of appropriate immunotherapy.

Authors: Wakerley, B; Uncini, A; Yuki, N

• Publisher: Nature Research
• Journal: Nature reviews. Neurology
• Volume: 10
• Issue: 9
• Pages: 537-544
• Publication date: 2014-09-01
• Acceptance date: 2024-11-13
• DOI: 10.1038/nrneurol.2014.138
• EISSN: 1759-4766
• ISSN: 1759-4758
• Language: English
• Keywords: Miller Fisher Syndrome; GBS Classification Group; Guillain-Barre Syndrome; Humans; Immunotherapy